FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic Cancer

NCT01688336 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
9
Enrollment
OTHER
Sponsor class

Stopped Results unlikely to impact treatment patterns. Time to complete not justified.

Conditions

Interventions

Sponsor

UNC Lineberger Comprehensive Cancer Center